Document is current
Any future updates will be listed below
-
Authors
Xinju, Zhao
Changying, Xing
Hong, Liu
Guisen, Li
Ping, Zhang
Caili, Wang
Zuying, Xiong
Gang, Xu
Rong, Wang
Rongshan, Li
Aili, Jiang
Hongli, Jiang
Jianxin, Wan
Xiaoling, Wang
Jing, Yang
Li, Yao
Pei, Wang
Rui, Zhang
Yunhua, Liao
Huimin, Luo
Jinsheng, Xu
Menghua, Chen
Yinhui, Li
Qinkai, Chen
Zhongfei, Yuan
Yan, Zha
Hong, Li
Wenbo, Hu
Chen, Lu
Zhaohui, Ni
Lingling, Gao
Li, Zuo
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05020717 at ClinicalTrials.govDocuments that mention this clinical trial
Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol
https://doi.org/10.1136/bmjopen-2022-066394
Prevalence, practice pattern, and mortality of hyperkalemia in Chinese patients undergoing hemodialysis in the visualize HD study
https://doi.org/10.1038/s41598-025-92609-1
-
Funding
Funding for this research was provided by:
AstraZeneca
ZGC Nephrology & Blood Purification Innovation Alliance
- License Information
-
More Information
Article History
Received: 14 May 2024
Accepted: 1 March 2025
First Online: 1 July 2025
Declarations
:
: The authors declare no competing interests.
